Literature DB >> 11587811

Detection of adverse events: what are the current sensitivity limits during clinical development?

B Fritzell1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11587811     DOI： 10.1016/s0264-410x(01)00291-2

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  7 in total

1.  The case for a vaccine injury compensation program for Canada.

Authors:  Kumanan Wilson; Jennifer Keelan
Journal:  Can J Public Health       Date:  2012 Mar-Apr

2.  What should an ideal vaccine postlicensure safety system be?

Authors:  Marie R Griffin; M Miles Braun; Kenneth J Bart
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

3.  Safety of 9-valent human papillomavirus vaccine administration among pregnant women: Adverse event reports in the Vaccine Adverse Event Reporting System (VAERS), 2014-2017.

Authors:  Claudia S Landazabal; Pedro L Moro; Paige Lewis; Saad B Omer
Journal:  Vaccine       Date:  2019-01-16       Impact factor: 3.641

Review 4.  Data mining in the US using the Vaccine Adverse Event Reporting System.

Authors:  John Iskander; Vitali Pool; Weigong Zhou; Roseanne English-Bullard
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

5.  Adverse events following 12 and 18 month vaccinations: a population-based, self-controlled case series analysis.

Authors:  Kumanan Wilson; Steven Hawken; Jeffrey C Kwong; Shelley Deeks; Natasha S Crowcroft; Carl Van Walraven; Beth K Potter; Pranesh Chakraborty; Jennifer Keelan; Michael Pluscauskas; Doug Manuel
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

6.  T-cell receptor excision circle levels and safety of paediatric immunization: A population-based self-controlled case series analysis.

Authors:  Kumanan Wilson; Daniel Rodriguez Duque; Malia S Q Murphy; Steven Hawken; Anne Pham-Huy; Jeffrey Kwong; Shelley L Deeks; Beth K Potter; Natasha S Crowcroft; Dennis E Bulman; Pranesh Chakraborty; Julian Little
Journal:  Hum Vaccin Immunother       Date:  2018-02-26       Impact factor: 3.452

7.  The Canadian National Vaccine Safety Network: surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada.

Authors:  Julie A Bettinger; Manish Sadarangani; Gaston De Serres; Louis Valiquette; Otto G Vanderkooi; James D Kellner; Matthew P Muller; Karina A Top; Jennifer E Isenor; Allison McGeer; Kimberly Marty
Journal:  BMJ Open       Date:  2022-01-20       Impact factor: 2.692
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.